纳洛酮治疗阿片类药物过量相关的肺部并发症
该回顾性、观察性、横断面研究纳入匹兹堡市紧急医疗服务系统救治的1831例接受纳洛酮治疗的阿片类药物过量患者,收集院前与院内记录,评估纳洛酮剂量、给药途径与临床结局(肺水肿、误吸性肺炎、误吸性肺炎症)。高剂量定义为总给药量超过4.4 mg。结果显示高剂量组肺部并发症绝对风险42% vs 26%,OR 2.14(95%CI 1.44–3.18),多因素回归校正后OR 1.85(95%CI 1.12–3.04);初始剂量超过0.4 mg时风险27% vs 13%(OR 2.57,95%CI 1.45–4.54)。肺水肿发生率为1.1%。作者结论为高剂量纳洛酮与更高肺部并发症率相关,需前瞻性研究确定因果关系。
要点
- 院前阿片类过量患者纳洛酮总剂量超过4.4 mg者肺部并发症绝对风险42%,未超过4.4 mg者26%,OR 2.14(95%CI 1.44–3.18)。
- 多因素logistic回归校正给药途径与病前合并症后,高剂量纳洛酮与肺部并发症的关联仍显著,OR 1.85(95%CI 1.12–3.04)。
- 初始纳洛酮剂量超过0.4 mg者肺部并发症风险27%,未超过0.4 mg者13%,OR 2.57(95%CI 1.45–4.54)。
- 全部患者中肺水肿发生率为1.1%。
- 作者结论:院前阿片类过量治疗中较高剂量纳洛酮与更高肺部并发症率相关,需前瞻性研究确定因果关系。
适用人群与场景
- 由匹兹堡市紧急医疗服务局(City of Pittsburgh Bureau of Emergency Medical Services)以纳洛酮治疗的阿片类药物过量患者,共1831例。
诊断标准与关键阈值
- 高剂量纳洛酮定义为总给药量超过4.4 mg;初始剂量分析以0.4 mg为界。
- 肺部并发症包括肺水肿、误吸性肺炎、误吸性肺炎症。
研究设计与关键结果
- 研究类型为回顾性、观察性、横断面研究,样本量1831例,人群为匹兹堡市紧急医疗服务系统以纳洛酮治疗的阿片类药物过量患者;干预/暴露为院前纳洛酮给药剂量(高剂量定义为总量超过4.4 mg),对照为较低剂量;主要终点为肺部并发症(肺水肿、误吸性肺炎、误吸性肺炎症)。
- 高剂量组(总剂量超过4.4 mg)肺部并发症绝对风险42% vs 较低剂量组26%,OR 2.14(95%CI 1.44–3.18),原文报告高剂量组风险高62%。
- 多因素logistic回归校正给药途径与病前合并症后,高剂量纳洛酮与肺部并发症的关联仍显著,OR 1.85(95%CI 1.12–3.04)。
- 次要分析:初始纳洛酮剂量超过0.4 mg者肺部并发症风险27% vs 未超过0.4 mg者13%,OR 2.57(95%CI 1.45–4.54)。
- 全部患者中肺水肿发生率为1.1%。
证据类型、等级与局限
- 证据类型:回顾性、观察性、横断面研究。
- 局限:原文未报告局限性;作者在结论中指出需前瞻性研究确定该关系的因果关系。
对床旁实践的改变
- 作者结论认为院前阿片类过量治疗中较高剂量纳洛酮与更高肺部并发症率相关,并指出需前瞻性研究确定因果关系。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
STUDY OBJECTIVE: We aim to determine whether administration of higher doses of naloxone for the treatment of opioid overdose is associated with increased pulmonary complications.
METHODS: This was a retrospective, observational, cross-sectional study of 1,831 patients treated with naloxone by the City of Pittsburgh Bureau of Emergency Medical Services. Emergency medical services and hospital records were abstracted for data in regard to naloxone dosing, route of administration, and clinical outcomes, including the development of complications such as pulmonary edema, aspiration pneumonia, and aspiration pneumonitis. For the purposes of this investigation, we defined high-dose naloxone as total administration exceeding 4.4 mg. Multivariable analysis was used to attempt to account for confounders such as route of administration and pretreatment morbidity.
RESULTS: Patients receiving out-of-hospital naloxone in doses exceeding 4.4 mg were 62% more likely to have a pulmonary complication after opioid overdose (42% versus 26% absolute risk; odds ratio 2.14; 95% confidence interval 1.44 to 3.18). This association remained statistically significant after multivariable analysis with logistic regression (odds ratio 1.85; 95% confidence interval 1.12 to 3.04). A secondary analysis showed an increased risk of 27% versus 13% (odds ratio 2.57; 95% confidence interval 1.45 to 4.54) when initial naloxone dosing exceeded 0.4 mg. Pulmonary edema occurred in 1.1% of patients.
CONCLUSION: Higher doses of naloxone in the out-of-hospital treatment of opioid overdose are associated with a higher rate of pulmonary complications. Furthermore, prospective study is needed to determine the causality of this relationship.
参考来源
- Farkas A, Lynch MJ, Westover R, et al. Pulmonary Complications of Opioid Overdose Treated With Naloxone. Ann Emerg Med. 2019. PMID: 31182316. doi:10.1016/j.annemergmed.2019.04.006
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。